141 related articles for article (PubMed ID: 11966641)
1. Hypericin-based fluorescence diagnosis of bladder carcinoma.
D'Hallewin MA; Kamuhabwa AR; Roskams T; De Witte PA; Baert L
BJU Int; 2002 May; 89(7):760-3. PubMed ID: 11966641
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin.
D'Hallewin MA; De Witte PA; Waelkens E; Merlevede W; Baert L
J Urol; 2000 Aug; 164(2):349-51. PubMed ID: 10893582
[TBL] [Abstract][Full Text] [Related]
3. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?
Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW
BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence detection of bladder cancer: a review.
D'Hallewin MA; Bezdetnaya L; Guillemin F
Eur Urol; 2002 Nov; 42(5):417-25. PubMed ID: 12429148
[TBL] [Abstract][Full Text] [Related]
5. A phase IIA dose-finding study of PVP-hypericin fluorescence cystoscopy for detection of nonmuscle-invasive bladder cancer.
Straub M; Russ D; Horn T; Gschwend JE; Abrahamsberg C
J Endourol; 2015 Feb; 29(2):216-22. PubMed ID: 25222735
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin.
Kubin A; Meissner P; Wierrani F; Burner U; Bodenteich A; Pytel A; Schmeller N
Photochem Photobiol; 2008; 84(6):1560-3. PubMed ID: 18627521
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
Schmidbauer J; Marberger M
Curr Opin Urol; 2007 Sep; 17(5):347-51. PubMed ID: 17762629
[TBL] [Abstract][Full Text] [Related]
8. New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology.
Pytel A; Schmeller N
Urology; 2002 Feb; 59(2):216-9. PubMed ID: 11834388
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence detection of flat transitional cell carcinoma after intravesical instillation of aminolevulinic acid.
D'Hallewin MA; Vanherzeele H; Baert L
Am J Clin Oncol; 1998 Jun; 21(3):223-5. PubMed ID: 9626785
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic image analysis of photosensitizer fluorescence as a promising noninvasive approach for pathological grading of bladder cancer in situ.
Kah JC; Lau WK; Tan PH; Sheppard CJ; Olivo M
J Biomed Opt; 2008; 13(5):054022. PubMed ID: 19021402
[TBL] [Abstract][Full Text] [Related]
11. Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy.
Olivo M; Lau W; Manivasager V; Tan PH; Soo KC; Cheng C
Int J Oncol; 2003 Oct; 23(4):983-90. PubMed ID: 12963977
[TBL] [Abstract][Full Text] [Related]
12. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder.
Huygens A; Kamuhabwa AR; van Cleynenbreugel B; van Poppel H; Roskams T; de Witte PA
BJU Int; 2005 Feb; 95(3):436-41. PubMed ID: 15679810
[TBL] [Abstract][Full Text] [Related]
13. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
Kamuhabwa AA; Roskams T; Baert L; De Witte PA
Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090
[TBL] [Abstract][Full Text] [Related]
14. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
15. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
16. ["... The better to see you with"--phothodynamic diagnostic in superficial bladder cancer].
Forster TH; Wyler S; Ruszat R; Gasser TC; Bachmann A
Praxis (Bern 1994); 2007 Oct; 96(42):1631-7. PubMed ID: 17974123
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer.
Olivo M; Lucky SS; Kent Mancer JF; Lau WK
Urol Oncol; 2012 Sep; 30(5):624-34. PubMed ID: 20933443
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.
Kamuhabwa AA; Cosserat-Gerardin I; Didelon J; Notter D; Guillemin F; Roskams T; D'Hallewin MA; Baert L; de Witte PA
Int J Cancer; 2002 Jan; 97(2):253-60. PubMed ID: 11774272
[TBL] [Abstract][Full Text] [Related]
19. Significance of fluorescence cystoscopy for diagnosis of superficial bladder cancer after intravesical instillation of delta aminolevulinic acid.
Ehsan A; Sommer F; Haupt G; Engelmann U
Urol Int; 2001; 67(4):298-304. PubMed ID: 11741132
[TBL] [Abstract][Full Text] [Related]
20. Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography.
Ren H; Park KC; Pan R; Waltzer WC; Shroyer KR; Pan Y
J Urol; 2012 Mar; 187(3):1063-70. PubMed ID: 22245332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
